Gilead Sciences, Inc. shares have risen more than 43% over the past year. Click here to find out why GILD stock is a Sell.
Carfilzomib prevented BCMA degradation, increased target density, and improved CAR T susceptibility by ~26%–28% in vitro, while enhancing xenograft antitumor activity without worsening T-cell ...
News-Medical.Net on MSN
Brain injury protein in the blood could help estimate biological age in animals
The protein "neurofilament light chain" (NfL) – studied in humans in the context of neurodegenerative diseases and aging – is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results